Ireland - English - HPRA (Health Products Regulatory Authority)

rorer pharmaceuticals limited - calcitonin, porcine - pdr+solv for soln for inj - 160 international unit

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - cefalotin sodium, quantity: 1.058 g (equivalent: cefalotin, qty 1 g) - injection, powder for - excipient ingredients: sodium bicarbonate - indications: cephalothin sodium for injection is indicated for the treatment of serious infections caused by susceptible strains of the designated microorganisms in the diseases listed below. culture and susceptibility studies should be performed. however, therapy may be instituted before results of susceptibility studies are obtained (see pharmacology: microbiology). respiratory tract: infections caused by s. pneumoniae, staphylococci (penicillinase and nonpenicillinase producing), group a beta-haemolytic streptococci, klebsiella, and h. influenzae. skin and soft tissue: infections, including peritonitis, caused by staphylococci (penicillinase and nonpenicillinase producing), group a beta-haemolytic streptococci, e.coli, pr. mirabilis and klebsiella. genitourinary tract: infections caused by e. coli, pr. mirabilis and klebsiella. septicaemia, including endocarditis: infections caused by s. pneumoniae, staphylococci (penicillinase and nonpenicillinase producing), group a beta-haemolytic streptococci, s. viridans, e. coli, pr. mirabilis and klebsiella. bone and joint: infection caused by staphylococci (penicillinase and non-penicillinase producing). prophylactically in vaginal hysterectomy, head and neck surgery, insertion of prosthetic heart valves, and prosthetic arthroplasty. cephalothin is not recommended for gastrointestinal procedures or other sites where anaerobic organisms such as bacteriodes tend to prevail. dosage is required pre-, intra-and postoperatively (i.e perioperatively, see dosage and administration). if signs of postoperative infection develop, specimens should be cultured to identify the causative organism so that appropriate therapy can be instituted. note: if the susceptibility tests show that the causative organism is resistant to cephalothin, other appropriate antibiotic therapy should be instituted.

Ireland - English - HPRA (Health Products Regulatory Authority)

animedica gmbh - calcium gluconate monohydrate; calcium borogluconate; calcium hydroxide; magnesium chloride hexahydrate - solution for injection/infusion - 1.55, 21.45, 0.66, 3.25 grams/100 millilitres - calcium - cattle - vitamins and minerals

Ireland - English - HPRA (Health Products Regulatory Authority)

animedica gmbh - calcium gluconate monohydrate; calcium borogluconate; calcium hydroxide; magnesium chloride hexahydrate - solution for injection/infusion - 3.10, 42.960, 1.32, 6.50 grams/100 millilitres - calcium - cattle - vitamins and minerals

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

adcock ingram limited - injection - see ingredients - each 0,2 ml ampoule contains heparin calcium 5 ooo iu

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

the premier pharmaceutical co ltd - injection - see ingredients - each 0,5 ml ampoule contains heparin calcium 12 5oo iu

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

the premier pharmaceutical co ltd - injection - see ingredients - each 0,8 ml ampoule contains heparin calcium 20 000 iu

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

the premier pharmaceutical co ltd - injection - see ingredients - each 0,3 ml contains heparin calcium 7 500 units

Egypt - English - EDA (Egyptian Drug Authority)

ramco - injection - 2500 i.u./ml

Egypt - English - EDA (Egyptian Drug Authority)

ramco - injection - 2500 i.u./ml